Pages that link to "Q34034240"

The following pages link to TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer (Q34034240):

Displaying 42 items.

• Activators of G protein signaling in the kidney (Q26824228) (← links)
• Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer (Q31015478) (← links)
• Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemia (Q33648911) (← links)
• TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma (Q33688803) (← links)
• TRIP13 is a protein-remodeling AAA ATPase that catalyzes MAD2 conformation switching (Q35616366) (← links)
• The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy. (Q35872419) (← links)
• Integrated Analysis of Genome-Wide Copy Number Alterations and Gene Expression Profiling of Lung Cancer in Xuanwei, China (Q36240493) (← links)
• TRIP13-deficient tubular epithelial cells are susceptible to apoptosis following acute kidney injury (Q37679016) (← links)
• Quantitative Proteomic Analysis of Optimal Cutting Temperature (OCT) Embedded Core-Needle Biopsy of Lung Cancer (Q38430613) (← links)
• Pch2(TRIP13): controlling cell division through regulation of HORMA domains (Q38431480) (← links)
• Galanin modulates the neural niche to favour perineural invasion in head and neck cancer. (Q38881719) (← links)
• DNA repair in ischemic acute kidney injury (Q39032212) (← links)
• The Pch2 AAA ATPase promotes phosphorylation of the Hop1 meiotic checkpoint adaptor in response to synaptonemal complex defects (Q41117313) (← links)
• TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion (Q41421424) (← links)
• Identifying DNase I hypersensitive sites as driver distal regulatory elements in breast cancer (Q41621328) (← links)
• Corrigendum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer (Q42598614) (← links)
• Targeted Gene Sequencing of Gallbladder Carcinoma Identifies High-impact Somatic and Rare Germline Mutations (Q47434327) (← links)
• Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit. (Q47565999) (← links)
• Oncoprotein Tudor-SN is a key determinant providing survival advantage under DNA damaging stress (Q49830073) (← links)
• Study on the expression of TRIP13 mRNA in chronic lymphocytic leukemia B lymphocyte and the molecular mechanism of TRIP13 mediated JVM-2 cell proliferation and apoptosis (Q50502982) (← links)
• CDH11 inhibits proliferation and invasion in head and neck cancer (Q50786585) (← links)
• Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. (Q52607328) (← links)
• TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer. (Q52726523) (← links)
• SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer. (Q55496144) (← links)
• TRIP13 and APC15 drive mitotic exit by turnover of interphase- and unattached kinetochore-produced MCC (Q57810920) (← links)
• Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers (Q58093851) (← links)
• Meta-analysis of microarray datasets identify several chromosome segregation-related cancer/testis genes potentially contributing to anaplastic thyroid carcinoma (Q58569105) (← links)
• LncRNA TINCR is associated with clinical progression and serves as tumor suppressive role in prostate cancer (Q58735839) (← links)
• i-Motif DNA: structural features and significance to cell biology (Q58772561) (← links)
• Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-β1/smad3 (Q60044422) (← links)
• Integrative analysis with expanded DNA methylation data reveals common key regulators and pathways in cancers (Q61804474) (← links)
• Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4 (Q90166560) (← links)
• Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer (Q90208532) (← links)
• TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis (Q91329830) (← links)
• Insights into a Crucial Role of TRIP13 in Human Cancer (Q92005630) (← links)
• Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway (Q92135391) (← links)
• Elevated TRIP13 drives cell proliferation and drug resistance in bladder cancer (Q92512109) (← links)
• The oncogenic role of TRIP13 in regulating proliferation, invasion, and cell cycle checkpoint in NSCLC cells (Q92619051) (← links)
• Adaptive Responses to Monotherapy in Head and Neck Cancer: Interventions for Rationale-Based Therapeutic Combinations (Q92821373) (← links)
• Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p (Q97644127) (← links)
• ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer (Q98289643) (← links)
• Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma (Q99237957) (← links)